Serodiagnosis Profiling of Anti SARS-CoV-2 Among Blood Donor Surabaya Indonesia

https://doi.org/10.33860/jik.v17i4.3367

Authors

  • Evy Diah Woelansari Department of Medical Laboratory Technology, Health Polytechnic Surabaya, Indonesia
  • Retno Sasongkowati Department of Medical Laboratory Technology, Health Polytechnic Surabaya, Indonesia
  • Juliana Christiyaningsih Department of Medical Laboratory Technology, Health Polytechnic Surabaya, Indonesia

Keywords:

SARS-CoV-2, IgG, Antibody Protein, Blood Donor

Abstract

SARS-CoV-2 antibody detection is used as a response to natural infection and vaccination. Antibody response is very important in viral seroepidemiology and the potential role of antibodies in disease. This study was to determine serodiagnosis anti SARS-CoV-2 among blood donor Surabaya detect antibodies with protein molecular weight as serodiagnosis and immune response to SARS-CoV-2 in donors in Surabaya. The research used in this study was exploratory descriptive design. Samples from blood donors as many as 150 samples at UTD PMI Surabaya. The examination was carried out by detecting IgG SARS-CoV-2 antibodies ELISA method and followed by protein molecular weight examination SDS-PAGE method (semi-log The results of the ELISA method antibody examination showed that 67 people had IgG antibody titers against SARS-CoV2 (44.7%) and 83 people were negative (55.3%) (COI: 0.1535-0.1569). Furthermore, the results of the SDS- PAGE method examination obtained the average molecular weight in band 1: 49.73 kDA, band 2: 25.26 kDA; band 3: 19.63.4 kDA; band 4: 12.35 kDA and band 5: 7.33 kDA. There were IgG antibody of SARS CoV-2 in blood donor Surabaya meanwhile from protein screening results we could not find protein of spike SARS-CoV-2 in Blood donor Surabaya.

References

Irsan A, Mardhia M, Rialita A. Konsistensi Respon Imun Humoral (IgG) SARS-CoV-2 Pasca Vaksinasi SARS-CoV-2 pada Tenaga Kesehatan. Majalah Kedokteran Andalas. 2022 Apr 11;45(2):118-25.

Nidom AN, Madyawati SP, Rachmawati K, Rahmahani J, Santoso KP, Ansori AN, Nidom RV, Afifah B, Kusala MK, Prakoso D, Alamudi MY. Protection and profile of immune response against SARS-CoV-2 among the COVID-19 vaccinated and unvaccinated individuals. International Journal of Health Sciences. 2022;6(S5):6011-9.

Irsan A, Mardhia M, Rialita A. Evaluation of Humoral Response of Emergency Unit Healthcare Workers after Third Dose of COVID-19 Vaccination. Muhammadiyah Medical Journal. 2022 Jun 2;3(1):27-32.

Humairah I, Nidom RV, Indrasari S, Qurnianingsih E, Ansori AN, Normalina I, Nidom CA. Correlation Between Influenza Virus Replication and ATP6V0C of Trivalent Influenza (TIV) Vaccination in Ferret. Indian Journal of Forensic Medicine & Toxicology. 2020 Jul 30;14(3):1957-62.

Chunchu SR, Ravula U, Gente VK, Bacchu S, Pandu Ranga Rao S, Mooli S. SARS-CoV-2 seroprevalence among whole blood donors during first wave of covid-19 pandemic in India. Indian Journal of Hematology and Blood Transfusion. 2022 Jul;38(3):546-55.

Hajizadeh F, Khanizadeh S, Khodadadi H, Mokhayeri Y, Ajorloo M, Malekshahi A, Heydari E. SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study). Microbial pathogenesis. 2022 Jul 1;168:105595.

Banava S, Gansky SA, Reddy MS. Coronavirus disease update on epidemiology, virology, and prevention. Compendium of continuing education in dentistry (Jamesburg, NJ: 1995). 2021 Jun;42(6):280.

Klumpp-Thomas C, Kalish H, Drew M, Hunsberger S, Snead K, Fay MP, Mehalko J, Shunmugavel A, Wall V, Frank P, Denson JP. Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling. Nature communications. 2021 Jan 4;12(1):113.

Yanti B, Ismida FD, Sarah KE. Perbedaan uji diagnostik antigen, antibodi, RT-PCR dan tes cepat molekuler pada Coronavirus Disease 2019. Jurnal Kedokteran Syiah Kuala. 2020 Dec 1;20(3).

Herrera NG, Morano NC, Celikgil A, Georgiev GI, Malonis RJ, Lee JH, Tong K, Vergnolle O, Massimi AB, Yen LY, Noble AJ. Characterization of the SARS-CoV-2 S protein: biophysical, biochemical, structural, and antigenic analysis. ACS omega. 2020 Dec 21;6(1):85-102.

Bakr S, Ezzat EM, Salem KM, Masoud M, Abdelaziz HE. Seroprevalence of SARS-CoV-2 immunoglobulin G antibody during COVID-19 pandemic in Fayoum District, Egypt: a community-based pilot survey. The Pan African Medical Journal. 2023;45.

Rikhtegaran Tehrani Z, Saadat S, Saleh E, Ouyang X, Constantine N, DeVico AL, Harris AD, Lewis GK, Kottilil S, Sajadi MM. Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays. PloS one. 2020 Nov 2;15(11):e0237828.

Nisnawati N, Niken N, Yusuf RN. Perbedaan jumlah limfosit pada tenaga kesehatan yang sudah menerima vaksin dosis lengkap dengan yang tidak menerima vaksin COVID-19 di RSUD Aceh Singkil. Jurnal Kesehatan Saintika Meditory. 2021 Nov 12;4(2):94-103.

Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, MacLaren G, Brodie D, Shekar K. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. The Lancet Respiratory Medicine. 2020 May 1;8(5):518-26.

Chang L, Hou W, Zhao L, Zhang Y, Wang Y, Wu L, Xu T, Wang L, Wang J, Ma J, Wang L. The prevalence of antibodies to SARS-CoV-2 among blood donors in China. Nature communications. 2021 Mar 2;12(1):1383.

Woelansari ED, Krihariyani D. Spike-Receptor Binding Domain (Srbd) Antibodies Secretion In Covid 19 Survivors And Non-Survivors Post-Pre-Endemic Vaccination. Folia Medica Indonesiana. 2022 Sep 1;58(3):256-60.1

Alandijany TA, El-Kafrawy SA, Al-Ghamdi AA, Qashqari FS, Faizo AA, Tolah AM, Hassan AM, Sohrab SS, Hindawi SI, Badawi MA, Azhar EI. Lack of antibodies to SARS-CoV-2 among blood donors during COVID-19 lockdown: a study from Saudi Arabia. InHealthcare 2021 Jan 5 (Vol. 9, No. 1, p. 51). MDPI.

Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, Sharifi N, Erzurum S, Eng C, Cheng F. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC medicine. 2020 Dec;18:1-8.

Published

2024-02-29

How to Cite

Woelansari, E. D., Sasongkowati, R., & Christiyaningsih, J. (2024). Serodiagnosis Profiling of Anti SARS-CoV-2 Among Blood Donor Surabaya Indonesia. Poltekita : Jurnal Ilmu Kesehatan, 17(4), 1621–1626. https://doi.org/10.33860/jik.v17i4.3367

Issue

Vol. 17 No. 4 (2024): February

Section

Original Articles
Copyright & Licensing
Copyright (c) 2024 Evy Diah Woelansari, Retno Sasongkowati, Juliana Christiyaningsih (Author)

Authors who publish with Poltekita : Jurnal Ilmu Kesehatan agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 2.0 Generic License.

Poltekita : Jurnal Ilmu Kesehatan  is licensed under a Creative Commons Attribution-Share Alike 4.0 International License

You are free to:

  • Adapt, remix, transform, and build upon the material for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

Similar Articles

<< < 1 2 3 4 > >> 

You may also start an advanced similarity search for this article.